$Antithymocyte globulin-induced refractory hypotension in renal transplantation recipient$

Antithymocyte globulin-induced refractory hypotension in renal transplantation recipient

Bibliographic Details
Main Authors:	Shamim Rafat, Sahu Sandeep, Siddiqui Tasneem, Agarwal Sanjay
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2017-01-01
Series:	Journal of Anaesthesiology Clinical Pharmacology
Online Access:	http://www.joacp.org/article.asp?issn=0970-9185;year=2017;volume=33;issue=3;spage=422;epage=423;aulast=Rafat

Similar Items

Clinical Correlates and Outcomes of Dual Basiliximab and Antithymocyte Globulin Induction in Kidney Transplant Recipients: A National Study
by: Ngan N. Lam, MD, et al.
Published: (2021-08-01)

Guillain–Barre syndrome after antithymocyte globulin administration in a kidney transplant recipient: A case report and literature review
by: Farnaz Tavakoli, et al.
Published: (2023-11-01)

Poor Patient and Graft Outcome After Induction Treatment by Antithymocyte Globulin in Recipients of a Kidney Graft After Nonrenal Organ Transplantation
by: Hoa Le Mai, PhD, et al.
Published: (2018-04-01)

PB2188: APPLICATION PROSPECT OF LOW DOSE PORCINE ANTITHYMOCYTE GLOBULIN IN HLA MATCHED SIBLING DONOR TRANSPLANTATION
by: X. chen, et al.
Published: (2022-06-01)

Basiliximab vs. Antithymocyte Globulin as Initial Induction Therapy for Lung Transplantation: A National Two Years Review
by: Bruno Mendes, et al.
Published: (2022-08-01)

The comparative efficacy and safety of basiliximab and antithymocyte globulin in deceased donor kidney transplantation: a multicenter cohort study
by: Su Yeon Hong, et al.
Published: (2023-01-01)

Response to the second cycle of immunosuppressive therapy (antithymocyte globulin)in children with aplastic anemia
by: Rupamon Nongbet, et al.
Published: (2022-01-01)

P1394: DIFFERENT DOSES OF ANTITHYMOCYTE GLOBULIN (ATG) AS PART OF THE PREPARATIVE REGIMEN IN HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
by: S. Zhou, et al.
Published: (2022-06-01)

Antithymocyte globulin versus basiliximab induction for kidney transplantation in elderly patients: matched analysis within the Korean multicentric registry
by: Jun Young Lee, et al.
Published: (2022-09-01)

Outcome of children with severe acquired aplastic anemia treated with rabbit antithymocyte globulin and cyclosporine A
by: Marlene Pereira Garanito, et al.
Published: (2014-09-01)

Long-term outcome of 25 children and adolescents with severe aplastic anemia treated with antithymocyte globulin
by: de-Medeiros C.R., et al.
Published: (2000-01-01)

P1329: POST-TRANSPLANT CYCLOPHOSPHAMIDE (PT-CY) VERSUS ANTITHYMOCYTE GLOBULIN (ATG) AS GVHD PROPHYLAXIS FOR MATCHED UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION.
by: F. Dachy, et al.
Published: (2022-06-01)

Eltrombopag Preserves the Clonogenic Potential of Hematopoietic Stem Cells During Treatment With Antithymocyte Globulin in Patients With Aplastic Anemia
by: Margherita Vieri, et al.
Published: (2023-06-01)

Acquired severe aplastic anemia treated with antithymocyte globulin and cyclosporine: An experience of regional cancer center, Western India
by: Ankit B Patel, et al.
Published: (2015-01-01)

Antithymocyte Globulin as Second-Line Therapy in Graves Orbitopathy—Preliminary Results From a Prospective Single-Center Study
by: Monika Sarnat-Kucharczyk, et al.
Published: (2022-05-01)

Graft-Versus-Host Disease Prophylaxis with Antithymocyte Globulin in Patients Receiving Stem Cell Transplantation from Unrelated Donors: An Observational Retrospective Single-Center Study
by: Mariella Lo Schirico, et al.
Published: (2023-05-01)

PB2177: ANTITHYMOCYTE GLOBULIN AS TREATMENT OF ACUTE GRAFT VERSUS HOST DISEASE - 10 YEARS OF EXPERIENCE AT A SINGLE-CENTER
by: C. Dantas Rodrigues, et al.
Published: (2022-06-01)

Fludarabine–Cyclophosphamide-Based Conditioning with Antithymocyte Globulin Serotherapy Is Associated with Durable Engraftment and Manageable Infections in Children with Severe Aplastic Anemia
by: Małgorzata Salamonowicz-Bodzioch, et al.
Published: (2021-09-01)

Antithymocyte Globulin Inhibits CD8<sup>+</sup> T Cell Effector Functions via the Paracrine Induction of PDL-1 on Monocytes
by: Dragan Copic, et al.
Published: (2023-01-01)

Antithymocyte Globulin Plus Post-Transplant Cyclophosphamide Combination as an Effective Strategy for Graft-versus-Host Disease Prevention in Haploidentical Peripheral Blood Stem Cell Transplantation for Children with High-Risk Malignancies
by: Kang-Hsi Wu, et al.
Published: (2022-11-01)

Trimethoprim-induced hyperkalemia in renal transplant recipient
by: Abhijeet S More, et al.
Published: (2018-01-01)

Refractory Giardiasis in a kidney transplant recipient
by: F. Yoonus, et al.
Published: (2021-02-01)

Orthostatic hypotension as the initial presentation of disseminated cryptococcosis in a kidney transplant recipient
by: Sophie Gough, et al.
Published: (2022-01-01)

CYCLOSPORINE-INDUCED GINGIVAL OVERGROWTH IN RENAL TRANSPLANT RECIPIENTS
by: Ana Maria Filioreanu, et al.
Published: (2018-07-01)

Osteomyelitis due to Mycobacterium haemophilum in an adult renal transplant recipient
by: Benjamin Chen, et al.
Published: (2023-01-01)

Melanomas in renal transplant recipients.
by: Le Mire, L, et al.
Published: (2006)

Dyslipidemia in Renal Transplant Recipients
by: Karolina Chmielnicka, et al.
Published: (2022-05-01)

Malignancy in Renal Transplant Recipients
by: Ergün Parmaksız, et al.
Published: (2019-03-01)

B-cell-rich T-cell lymphoma associated with Epstein-Barr virus-reactivation and T-cell suppression following antithymocyte globulin therapy in a patient with severe aplastic anemia
by: Nobuyoshi Hanaoka, et al.
Published: (2015-09-01)

Evaluating anti-thymocyte globulin induction doses for better allograft and patient survival in Asian kidney transplant recipients
by: Ye Eun Shim, et al.
Published: (2023-08-01)

Seborrhoeic dermatitis in renal transplant recipients
by: Lary, A, et al.
Published: (2007)

Gout in pediatric renal transplant recipients.
by: Trück, J, et al.
Published: (2010)

Skin cancers in renal transplant recipients
by: Bordea, C
Published: (2001)

Infective complications in the renal transplant recipients
by: Giuseppina Rosso, et al.
Published: (2024-02-01)

Predictors of Hyperparathyroidism in Renal Transplant Recipients
by: Houssaini Tarik, et al.
Published: (2008-01-01)

P1364: HLA MISMATCHED UNRELATED STEM CELL TRANSPLANTATION USING ANTITHYMOCYTE GLOBULIN IS A SUITABLE ALTERNATIVE FOR PATIENTS LACKING HLA-MATCHED UNRELATED DONORS: SINGLE CENTER LONG-TERM FOLLOW-UP DATA ANAL
by: L. Wang, et al.
Published: (2022-06-01)

Comparison of palonosetron and ondansetron in preventing postoperative nausea and vomiting in renal transplantation recipients: a randomized clinical trial
by: Tanvi Bhargava, et al.
Published: (2024-01-01)

Lymphoproliferative disorders in Oxford renal transplant recipients.
by: Bates, W, et al.
Published: (2003)

Tuberculosis in Renal Transplant Recipients: The Evidence for Prophylaxis
by: Currie, A, et al.
Published: (2010)

Hypertrophic pseudofolliculitis in white renal transplant recipients.
by: Lally, A, et al.
Published: (2007)